> Imprima

When to treat CLL

Ultima Vez Modificado: 11 de mayo del 2003


Dear OncoLink "Ask The Experts,"
I was diagnosed with chronic lymphocytic leukemia (CLL) about 1 1/2 years ago. Today my white count is 27.5. I am going to start a five-week treatment of Rituxan. Is it really time to start? From what I have read, it seems early. 


Selina M. Luger, MD, Director of the Leukemia Program and Assistant Professor of Medicine at the University of Pennsylvania, responds:

The decision to treat patients with CLL is not based on the absolute white blood count. We take into account how rapidly the white blood count rises as well as the effect the CLL has had on the liver, the spleen, the lymph nodes and the other blood counts (hemoglobin and platelets). It would be reasonable to discuss with your doctor what the reasons are for starting treatment at this time.


In Celebration of Eric Ott
by Bob Riter
August 17, 2015

Related News

Fludarabine, Alemtuzumab Combo Ups Survival in CLL

Oct 12, 2011

But combination therapy is associated with more adverse events than fludarabine monotherapy

FDA Expands Imbruvica Approval to Include CLL

Feb 14, 2014

Approval of Imbruvica (ibrutinib) expanded to include people with chronic lymphocytic leukemia

ASCO: Rx Strategies Promising for CLL, Non-Hodgkin's Lymphoma

Jun 2, 2015

Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma